RECORD // Company

Rigel Pharmaceuticals Inc

Formerly: RIGEL PHARMACEUTICALS INC

Built 2026-11-21T11:39:26Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (2 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

Gleif lei (1)
SEC EDGAR (1)
Matched by name only, not merged (9)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • Rigel Pharmaceuticals Inc · Ca business · same registered legal name as 'RIGEL PHARMACEUTICALS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • RIGEL PHARMACEUTICALS, INC. · Ct business · same registered legal name as 'RIGEL PHARMACEUTICALS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • Rigel Pharmaceuticals · Ctgov · exact name match to 'RIGEL PHARMACEUTICALS INC' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • Rigel Pharmaceuticals,Inc. · Ctgov · same registered legal name as 'RIGEL PHARMACEUTICALS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • RIGEL PHARMACEUTICALS, INC · East licences · same registered legal name as 'RIGEL PHARMACEUTICALS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • RIGEL PHARMACEUTICALS, INC. · East licences · same registered legal name as 'RIGEL PHARMACEUTICALS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • RIGEL PHARMACEUTICALS, INC. · Epa echo · same registered legal name as 'RIGEL PHARMACEUTICALS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • RIGEL PHARMACEUTICALS, INC. · Ny corps · same registered legal name as 'RIGEL PHARMACEUTICALS INC' Possible match based on name, not a shared identifier. Compare the records. Compare
  • RIGEL PHARMACEUTICALS INC · USAspending · same registered legal name as 'RIGEL PHARMACEUTICALS INC' Possible match based on name, not a shared identifier. Compare the records. Compare

6 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-05 · accession 0001034842-26-000061

ItemValuePeriodFormFiledAccessionReport
Revenue$80,890,0003 months ended 2026-09-3010-Q2026-11-050001034842-26-0000612026-11-21 11:39 UTCReport an error
Net income (loss)$13,185,0003 months ended 2026-09-3010-Q2026-11-050001034842-26-0000612026-11-21 11:39 UTCReport an error
Interest expense$257,0003 months ended 2026-09-3010-Q2026-11-050001034842-26-0000612026-11-21 11:39 UTCReport an error
Cash and cash equivalents$46,646,000at 2026-09-3010-Q2026-11-050001034842-26-0000612026-11-21 11:39 UTCReport an error
Contract liabilities, current (from an earlier report)$1,355,000at 2025-12-3110-K2026-03-030001034842-26-0000152026-11-21 11:39 UTCReport an error
Debt due in the next 12 months (from an earlier report)$22,500,000at 2026-03-3110-Q2026-05-050001034842-26-0000322026-11-21 11:39 UTCReport an error

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001034842
Ticker
RIGL
EIN
943248524
UEI
X7MHPBCMHFM3
CUSIP
766559702
Record ID
sx:sec:0001034842

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

29 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-16SEC EDGAR company profile2026-11-21 11:39 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-16SEC EDGAR company profile2026-11-21 11:39 UTCReport an error
State of incorporationDE2026-11-16SEC EDGAR company profile2026-11-21 11:39 UTCReport an error
Fiscal year end (MMDD)12312026-11-16SEC EDGAR company profile2026-11-21 11:39 UTCReport an error
Business address611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 940802026-11-16SEC EDGAR company profile2026-11-21 11:39 UTCReport an error
ExchangesNasdaq2026-11-16SEC EDGAR company profile2026-11-21 11:39 UTCReport an error
Revenue (fiscal year ended 2025-12-31)$294,282,0002025-12-3110-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax2026-11-21 11:39 UTCReport an error
Net income (loss) (fiscal year ended 2025-12-31)$367,024,0002025-12-3110-K, XBRL NetIncomeLoss2026-11-21 11:39 UTCReport an error
Total assets (at 2025-12-31)$513,594,0002025-12-3110-K, XBRL Assets2026-11-21 11:39 UTCReport an error
Stockholders' equity (at 2025-12-31)$391,480,0002025-12-3110-K, XBRL StockholdersEquity2026-11-21 11:39 UTCReport an error
Cash and cash equivalents (at 2025-12-31)$40,580,0002025-12-3110-K, XBRL CashAndCashEquivalentsAtCarryingValue2026-11-21 11:39 UTCReport an error
Operating cash flow (fiscal year ended 2025-12-31)$75,655,0002025-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-21 11:39 UTCReport an error
Long-term debt (at 2025-12-31)$52,500,0002025-12-3110-K, XBRL LongTermDebt2026-11-21 11:39 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-11-05)On November 5, 2026, Rigel Pharmaceuticals, Inc. (“Rigel”) announced certain financial results for its third quarter ended September 30, 2026. A copy of Rigel’s press release, titled “Rigel Reports Third Quarter 2026 Financial Results” is furnished pursuant to Item 2.02 as Exhibit 99.1 hereto. The information in this report, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by…2026-11-05SEC EDGAR 8-K 0001034842-26-000062 (text as filed, excerpt)2026-11-21 11:39 UTCReport an error
8-K Item 2.02, Results of Operations and Financial Condition (filed 2026-08-04)On August 4, 2026, Rigel Pharmaceuticals, Inc. (“Rigel”) announced certain financial results for its second quarter ended June 30, 2026. A copy of Rigel’s press release, titled “Rigel Reports Second Quarter 2026 Financial Results” is furnished pursuant to Item 2.02 as Exhibit 99.1 hereto. The information in this report, including the exhibit hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be incorporated by reference…2026-08-04SEC EDGAR 8-K 0001034842-26-000053 (text as filed, excerpt)2026-11-21 11:39 UTCReport an error
Plan (pension, plan no. 001)RIGEL PHARMACEUTICALS INC. 401(K) PLAN: 306 participants, assets $73,773,2632025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-21 11:39 UTCReport an error
Plan (welfare, plan no. 501)RIGEL PHARMACEUTICALS CONSOLIDATED WELFARE PLAN: 178 participants2025-12-31DOL EBSA Form 5500 public datasets (dataset)2026-11-21 11:39 UTCReport an error
Largest institutional holder #1 (13F as filed): BlackRock, Inc.$75,885,6902026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #2 (13F as filed): Soleus Capital Management, L.P.$72,117,8762026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #3 (13F as filed): ARMISTICE CAPITAL, LLC$65,408,6402026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #4 (13F as filed): STATE STREET CORP$40,684,5652026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #5 (13F as filed): VANGUARD CAPITAL MANAGEMENT LLC$30,713,3862026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #6 (13F as filed): AMERICAN CENTURY COMPANIES INC$29,016,0082026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #7 (13F as filed): D. E. Shaw & Co., Inc.$21,224,1262026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #8 (13F as filed): GEODE CAPITAL MANAGEMENT, LLC$18,906,3532026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #9 (13F as filed): MARSHALL WACE, LLP$14,372,4142026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Largest institutional holder #10 (13F as filed): CM Management, LLC$9,780,0002026-06-30SEC Form 13F data sets (quarterly; holdings as filed)2026-11-21 11:39 UTCReport an error
Federal award transactions, fiscal year 2026 (this one registration only)$02026-09-30USAspending recipient profile2026-11-21 11:39 UTCReport an error
Number of federal award transactions, fiscal year 2026 (this one registration only)32026-09-30USAspending recipient profile2026-11-21 11:39 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.